APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sumatriptan Succinate

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sumatriptan Succinate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025180 pages

Choose your research edition.

Industry ResearchSumatriptan Succinate Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Sumatriptan Succinate Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Sumatriptan Succinate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sumatriptan Succinate Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Sumatriptan Succinate Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Sumatriptan Succinate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sumatriptan Succinate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sumatriptan Succinate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sumatriptan Succinate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sumatriptan Succinate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sumatriptan Succinate include Teva, Merck, Mylan, Pfizer, Sun Pharmaceutical, GlaxoSmithKline and Endo Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sumatriptan Succinate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sumatriptan Succinate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sumatriptan Succinate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sumatriptan Succinate market size, projected growth trends, production technologies, key applications, and end-use industries.

Sumatriptan Succinate Segment by Company

Teva

Merck

Mylan

Pfizer

Sun Pharmaceutical

GlaxoSmithKline

Endo Pharmaceuticals

Sumatriptan Succinate Segment by Type

Tablet

Subcutaneous Injection

Nasal Spray

Sumatriptan Succinate Segment by Application

Hospital Pharmacies

Drug Stores

Sumatriptan Succinate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sumatriptan Succinate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sumatriptan Succinate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sumatriptan Succinate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sumatriptan Succinate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sumatriptan Succinate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sumatriptan Succinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sumatriptan Succinate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sumatriptan Succinate Industry Trends Table 2. Sumatriptan Succinate Industry Drivers Table 3. Sumatriptan Succinate Industry Opportunities and Challenges Table 4. Sumatriptan Succinate Industry Restraints Table 5. Global Sumatriptan Succinate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sumatriptan Succinate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sumatriptan Succinate Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Sumatriptan Succinate Sales Market Share by Manufacturers Table 9. Global Sumatriptan Succinate Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sumatriptan Succinate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sumatriptan Succinate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sumatriptan Succinate Manufacturers, Product Type & Application Table 13. Global Sumatriptan Succinate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sumatriptan Succinate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Subcutaneous Injection Table 18. Major Manufacturers of Nasal Spray Table 19. Global Sumatriptan Succinate Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Sumatriptan Succinate Sales by Type (2021-2026) & (K Units) Table 21. Global Sumatriptan Succinate Sales by Type (2027-2032) & (K Units) Table 22. Global Sumatriptan Succinate Sales Market Share by Type (2021-2026) Table 23. Global Sumatriptan Succinate Sales Market Share by Type (2027-2032) Table 24. Global Sumatriptan Succinate Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Sumatriptan Succinate Revenue by Type (2021-2026) & (K Units) Table 26. Global Sumatriptan Succinate Revenue by Type (2027-2032) & (K Units) Table 27. Global Sumatriptan Succinate Revenue Market Share by Type (2021-2026) Table 28. Global Sumatriptan Succinate Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Pharmacies Table 30. Major Manufacturers of Drug Stores Table 31. Global Sumatriptan Succinate Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Sumatriptan Succinate Sales by Application (2021-2026) & (K Units) Table 33. Global Sumatriptan Succinate Sales by Application (2027-2032) & (K Units) Table 34. Global Sumatriptan Succinate Sales Market Share by Application (2021-2026) Table 35. Global Sumatriptan Succinate Sales Market Share by Application (2027-2032) Table 36. Global Sumatriptan Succinate Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Sumatriptan Succinate Revenue by Application (2021-2026) & (K Units) Table 38. Global Sumatriptan Succinate Revenue by Application (2027-2032) & (K Units) Table 39. Global Sumatriptan Succinate Revenue Market Share by Application (2021-2026) Table 40. Global Sumatriptan Succinate Revenue Market Share by Application (2027-2032) Table 41. Global Sumatriptan Succinate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Sumatriptan Succinate Sales by Region (2021-2026) & (K Units) Table 43. Global Sumatriptan Succinate Sales Market Share by Region (2021-2026) Table 44. Global Sumatriptan Succinate Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Sumatriptan Succinate Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Sumatriptan Succinate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Sumatriptan Succinate Sales by Country (2021-2026) & (K Units) Table 48. North America Sumatriptan Succinate Sales by Country (2027-2032) & (K Units) Table 49. Europe Sumatriptan Succinate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Sumatriptan Succinate Sales by Country (2021-2026) & (K Units) Table 51. Europe Sumatriptan Succinate Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Sumatriptan Succinate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Sumatriptan Succinate Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Sumatriptan Succinate Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Sumatriptan Succinate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Sumatriptan Succinate Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Sumatriptan Succinate Sales by Country (2027-2032) & (K Units) Table 58. Global Sumatriptan Succinate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Sumatriptan Succinate Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Sumatriptan Succinate Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Sumatriptan Succinate Revenue Market Share by Region (2021-2026) Table 62. Global Sumatriptan Succinate Revenue Market Share by Region (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Sumatriptan Succinate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Sumatriptan Succinate Product Portfolio Table 67. Teva Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Sumatriptan Succinate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck Sumatriptan Succinate Product Portfolio Table 72. Merck Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Sumatriptan Succinate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Mylan Sumatriptan Succinate Product Portfolio Table 77. Mylan Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Sumatriptan Succinate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pfizer Sumatriptan Succinate Product Portfolio Table 82. Pfizer Recent Development Table 83. Sun Pharmaceutical Company Information Table 84. Sun Pharmaceutical Business Overview Table 85. Sun Pharmaceutical Sumatriptan Succinate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sun Pharmaceutical Sumatriptan Succinate Product Portfolio Table 87. Sun Pharmaceutical Recent Development Table 88. GlaxoSmithKline Company Information Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Sumatriptan Succinate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Sumatriptan Succinate Product Portfolio Table 92. GlaxoSmithKline Recent Development Table 93. Endo Pharmaceuticals Company Information Table 94. Endo Pharmaceuticals Business Overview Table 95. Endo Pharmaceuticals Sumatriptan Succinate Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Endo Pharmaceuticals Sumatriptan Succinate Product Portfolio Table 97. Endo Pharmaceuticals Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Sumatriptan Succinate Distributors List Table 101. Sumatriptan Succinate Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Sumatriptan Succinate Product Image Figure 2. Global Sumatriptan Succinate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sumatriptan Succinate Market Size (2021-2032) & (US$ Million) Figure 4. Global Sumatriptan Succinate Sales (2021-2032) & (K Units) Figure 5. Global Sumatriptan Succinate Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sumatriptan Succinate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Subcutaneous Injection Image Figure 10. Nasal Spray Image Figure 11. Global Sumatriptan Succinate Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Sumatriptan Succinate Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Sumatriptan Succinate Sales Market Share by Type (2021-2032) Figure 14. Global Sumatriptan Succinate Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Sumatriptan Succinate Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Sumatriptan Succinate Revenue Market Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Drug Stores Image Figure 19. Global Sumatriptan Succinate Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Sumatriptan Succinate Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Sumatriptan Succinate Sales Market Share by Application (2021-2032) Figure 22. Global Sumatriptan Succinate Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Sumatriptan Succinate Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Sumatriptan Succinate Revenue Market Share by Application (2021-2032) Figure 25. North America Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Sumatriptan Succinate Sales Market Share by Country (2021-2032) Figure 27. U.S. Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Sumatriptan Succinate Sales Market Share by Country (2021-2032) Figure 32. Germany Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Sumatriptan Succinate Sales Market Share by Country (2021-2032) Figure 39. China Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Sumatriptan Succinate Sales Market Share by Country (2021-2032) Figure 47. Brazil Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Sumatriptan Succinate Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Sumatriptan Succinate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Sumatriptan Succinate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Sumatriptan Succinate Revenue (2021-2032) & (US$ Million) Figure 58. North America Sumatriptan Succinate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Sumatriptan Succinate Revenue (2021-2032) & (US$ Million) Figure 60. Europe Sumatriptan Succinate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Sumatriptan Succinate Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Sumatriptan Succinate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Sumatriptan Succinate Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Sumatriptan Succinate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Sumatriptan Succinate Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Sumatriptan Succinate Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Subcutaneous Injection
  • Nasal Spray
Applications
  • Hospital Pharmacies
  • Drug Stores
Companies covered
  • Teva
  • Merck
  • Mylan
  • Pfizer
  • Sun Pharmaceutical
  • GlaxoSmithKline
  • Endo Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sumatriptan Succinate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sumatriptan Succinate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sumatriptan Succinate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sumatriptan Succinate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sumatriptan Succinate Market Dynamics
  1. 2.1 Sumatriptan Succinate Industry Trends
  2. 2.2 Sumatriptan Succinate Industry Drivers
  3. 2.3 Sumatriptan Succinate Industry Opportunities and Challenges
  4. 2.4 Sumatriptan Succinate Industry Restraints
3 Sumatriptan Succinate Market by Manufacturers
  1. 3.1 Global Sumatriptan Succinate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sumatriptan Succinate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sumatriptan Succinate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sumatriptan Succinate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sumatriptan Succinate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sumatriptan Succinate Manufacturers, Product Type & Application
  7. 3.7 Global Sumatriptan Succinate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sumatriptan Succinate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sumatriptan Succinate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sumatriptan Succinate Tier 1, Tier 2, and Tier 3
4 Sumatriptan Succinate Market by Type
  1. 4.1 Sumatriptan Succinate Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Subcutaneous Injection
  4. 4.1.3 Nasal Spray
  5. 4.2 Global Sumatriptan Succinate Sales by Type
  6. 4.2.1 Global Sumatriptan Succinate Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sumatriptan Succinate Sales by Type (2021-2032)
  8. 4.2.3 Global Sumatriptan Succinate Sales Market Share by Type (2021-2032)
  9. 4.3 Global Sumatriptan Succinate Revenue by Type
  10. 4.3.1 Global Sumatriptan Succinate Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Sumatriptan Succinate Revenue by Type (2021-2032)
  12. 4.3.3 Global Sumatriptan Succinate Revenue Market Share by Type (2021-2032)
5 Sumatriptan Succinate Market by Application
  1. 5.1 Sumatriptan Succinate Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.2 Global Sumatriptan Succinate Sales by Application
  5. 5.2.1 Global Sumatriptan Succinate Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sumatriptan Succinate Sales by Application (2021-2032)
  7. 5.2.3 Global Sumatriptan Succinate Sales Market Share by Application (2021-2032)
  8. 5.3 Global Sumatriptan Succinate Revenue by Application
  9. 5.3.1 Global Sumatriptan Succinate Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sumatriptan Succinate Revenue by Application (2021-2032)
  11. 5.3.3 Global Sumatriptan Succinate Revenue Market Share by Application (2021-2032)
6 Global Sumatriptan Succinate Sales by Region
  1. 6.1 Global Sumatriptan Succinate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sumatriptan Succinate Sales by Region (2021-2032)
  3. 6.2.1 Global Sumatriptan Succinate Sales by Region (2021-2026)
  4. 6.2.2 Global Sumatriptan Succinate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sumatriptan Succinate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sumatriptan Succinate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sumatriptan Succinate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sumatriptan Succinate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sumatriptan Succinate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sumatriptan Succinate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sumatriptan Succinate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sumatriptan Succinate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sumatriptan Succinate Revenue by Region
  1. 7.1 Global Sumatriptan Succinate Revenue by Region
  2. 7.1.1 Global Sumatriptan Succinate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sumatriptan Succinate Revenue by Region (2021-2026)
  4. 7.1.3 Global Sumatriptan Succinate Revenue by Region (2027-2032)
  5. 7.1.4 Global Sumatriptan Succinate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sumatriptan Succinate Revenue (2021-2032)
  8. 7.2.2 North America Sumatriptan Succinate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sumatriptan Succinate Revenue (2021-2032)
  11. 7.3.2 Europe Sumatriptan Succinate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sumatriptan Succinate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sumatriptan Succinate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sumatriptan Succinate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sumatriptan Succinate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Sumatriptan Succinate Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Sumatriptan Succinate Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Sumatriptan Succinate Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Sumatriptan Succinate Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Sun Pharmaceutical
  26. 8.5.1 Sun Pharmaceutical Company Information
  27. 8.5.2 Sun Pharmaceutical Business Overview
  28. 8.5.3 Sun Pharmaceutical Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sun Pharmaceutical Sumatriptan Succinate Product Portfolio
  30. 8.5.5 Sun Pharmaceutical Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Sumatriptan Succinate Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Endo Pharmaceuticals
  38. 8.7.1 Endo Pharmaceuticals Company Information
  39. 8.7.2 Endo Pharmaceuticals Business Overview
  40. 8.7.3 Endo Pharmaceuticals Sumatriptan Succinate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Endo Pharmaceuticals Sumatriptan Succinate Product Portfolio
  42. 8.7.5 Endo Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sumatriptan Succinate Value Chain Analysis
  2. 9.1.1 Sumatriptan Succinate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sumatriptan Succinate Production Mode & Process
  6. 9.2 Sumatriptan Succinate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sumatriptan Succinate Distributors
  9. 9.2.3 Sumatriptan Succinate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst